Late isolated central nervous system relapse in childhood B‐cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2-Reference-Cited by-同舟云学术

Late isolated central nervous system relapse in childhood B‐cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2

Published:2021-07-24 Issue:12 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hastings Caroline¹^ORCID,Chen Yichen²,Devidas Meenakshi²,Ritchey A. Kim³,Winick Naomi J.⁴^ORCID,Carroll William L.⁵,Hunger Stephen P.⁶,Wood Brent L.⁷,Marcus Robert B.⁸,Barredo Julio C.⁹^ORCID

Affiliation:

1. Department of Pediatrics, Division of Hematology Oncology University of California San Francisco Benioff Children's Hospital Oakland Oakland California USA

2. St. Jude Children's Research Hospital Memphis Tennessee USA

3. Department of Pediatrics, Division of Hematology Oncology University of Pittsburg Medical Center Children's Hospital of Pittsburg Pittsburg Pennsylvania USA

4. Department of Pediatrics University of Texas Southwestern Medical Center Dallas Texas USA

5. Department of Pediatrics, Division of Pediatric Hematology Oncology NYU Langone Medical Center New York City New York USA

6. Department of Pediatrics, Division of Oncology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

7. Department of Hematopathology Children's Hospital Los Angeles Los Angeles California USA

8. Department of Radiation Oncology Ascension Sacred Heart Hospital Pensacola Florida USA

9. Department of Pediatrics, Division of Pediatric Hematology Oncology University of Miami Miller School of Medicine Miami Florida USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29256

Reference47 articles.

1. Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

2. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

3. Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881

4. Relapsed childhood acute lymphoblastic leukaemia

5. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in children with first‐relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG‐ALL‐R08;Pediatric Blood & Cancer;2024-09-12

2. Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what’s next?;Leukemia & Lymphoma;2024-06-11

3. Nuanced Management of a Skull Base Tumor in the Setting of Relapsed Acute Lymphoblastic Leukemia;Journal of Neurological Surgery Reports;2024-04

4. INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2024-01

5. Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse;Journal of Clinical Oncology;2023-09-01